Related Experiment Video
Updated: Jun 11, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
223
Fear of progression after cancer recurrence: a mixed methods study
Ross James Stewart1, Gerald Michael Humphris2, Jayne Donaldson1
1Faculty of Health Sciences and Sport, University of Stirling, Stirling, United Kingdom.
Frontiers in Psychology
|October 10, 2024
Summary
Fear of cancer progression (FOP) significantly impacts quality of life in recurrent cancer patients. This study found moderate to dysfunctional FOP levels, highlighting the need for targeted psychosocial interventions to improve patient well-being.
Area of Science:
- Oncology
- Psychosocial Oncology
- Quality of Life Research
Background:
- Cancer recurrence significantly impacts patients' quality of life (QoL).
- Fear of cancer progression (FOP) is a common yet under-examined concern in recurrent cancer patients.
- High levels of FOP can negatively affect QoL.
Purpose of the Study:
- To longitudinally explore fear of cancer progression (FOP), health-related QoL, anxiety, and depression in patients with cancer recurrence.
- To assess cancer-specific and pandemic-related fears during the COVID-19 pandemic.
- To understand the psychosocial impact of cancer recurrence.
Main Methods:
- Sequential mixed-methods approach utilizing questionnaires and semi-structured interviews.
- 44 participants completed questionnaires at three monthly intervals.
- A sub-sample of 10 participants engaged in in-depth interviews.
Main Results:
- Moderate levels of FOP were observed, with over one-third experiencing dysfunctional levels.
- FOP remained stable over three months and was not linked to demographic or clinical factors.
- Mild anxiety and low depression were reported, alongside challenges to health-related QoL. Low concern regarding COVID-19 and cancer was noted.
Conclusions:
- Findings underscore the need for psychosocial interventions to manage FOP in recurrent cancer patients.
- Identifying and addressing FOP is crucial for enhancing patient well-being.
- Healthcare professionals should provide tailored support for the psychosocial impact of cancer recurrence.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.7K
Related Concept Videos
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:18Cancer
48.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.1K
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328